• Study on Reducing Chemotherapy Cycles with Pembrolizumab for Patients with PD-L1-Positive Recurrent or Metastatic Head and Neck Cancer

    Recruiting

    2 1 1 1
    France
  • Study on MK-2870, Pembrolizumab, and Chemotherapy for Patients with Advanced Gastroesophageal Cancer

    Recruiting

    1 1 1 1
    Investigated diseases:
    France Germany Italy Norway
  • Study Comparing Inotuzumab Ozogamicin to Drug Combination for Children with High-Risk Relapsed B-cell Acute Lymphoblastic Leukemia

    Recruiting

    2 1 1 1
    Investigated diseases:
    Austria Belgium Czechia Denmark Finland France +10
  • Study on the Effectiveness and Safety of Guselkumab for Children with Moderate to Severe Crohn’s Disease

    Recruiting

    3 1
    Investigated diseases:
    Investigated drugs:
    Austria Belgium France Italy The Netherlands Norway +3
  • Comparison of General Anesthesia versus High-Flow Nasal Cannula Sedation in Patients with Acute Ischemic Stroke Undergoing Endovascular Treatment

    Recruiting

    3 1 1 1
    Investigated diseases:
    Spain
  • Study on Liver Cancer in Cirrhosis Patients Using Idarubicin and Lipiodol Injection

    Recruiting

    2 1 1 1
    Investigated diseases:
    France
  • Study of GS030 gene therapy safety and tolerability in patients with Retinitis Pigmentosa

    Recruiting

    1 1 1
    Investigated diseases:
    France
  • Study on Isatuximab for Treating Pure Red Cell Aplasia in Patients with Major ABO Mismatch After Stem Cell Transplantation

    Recruiting

    2 1 1 1
    Investigated diseases:
    Investigated drugs:
    France
  • Study for Patients with BRCA Mutated Ovarian, Breast, Pancreatic, Prostate, and Endometrial Cancers Continuing Olaparib Treatment

    Recruiting

    3 1 1 1
    Investigated drugs:
    Belgium Bulgaria Czechia France Germany Hungary +6
  • Study on the Effects of Ticagrelor and Rivaroxaban in Patients with Atrial Fibrillation After Coronary Stent Surgery

    Recruiting

    3 1 1 1
    Belgium France Germany Italy The Netherlands Poland +1

powered by